Anniina Snellman
Docent
aepakk@utu.fi +358 0 231 3872 Kiinamyllynkatu 4-8 Turku |
2 of 3
- Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burdenPlasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals (2023)
- Alzheimer's and DementiaBrain Communications
- ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease - Study Protocol and Baseline CharacteristicsProdromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study (2022)
- Frontiers in NeurologyTheranostics
- Biomarkers of brain injury in patients with stress-related exhaustion: A longitudinal study (2022)
- Psychoneuroendocrinology
- CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design (2022)
- Alzheimer's and Dementia
- Neuropsykologiset tehtäväsarjat Alzheimerin taudin prekliinisen vaiheen hienoisen kognitiivisen heikentymisen havaitsemisessa (2022)
- Duodecim
- N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases (2022)
- Brain
- Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative (2021)
- Alzheimer's Research and Therapy
- Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy (2021)
- NeurologyMolecular Psychiatry
- Effects of pre-analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration (2021)
- Alzheimer's & dementia: diagnosis, assessment & disease monitoringScientific Reports
- Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease (2021)
- JAMA NeurologyScientific Reports
- (2021)
- (2021)
- P-tau235: a novel biomarker for staging preclinical Alzheimer's disease (2021)
- Embo molecular medicine
- (S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer's disease (2021)
- Neuropharmacology
- Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum (2021)
- Brain
- Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease (2021)
- Journal of Internal Medicine
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative (2020)
- Effect of genotype and age on cerebral [F-18]FDG uptake varies between transgenic APP(swe)-PS1(dE9) and Tg2576 mouse models of Alzheimer's disease (2019)
- Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer's Disease (2018)
- [F-18]FMPEP-d(2) PET imaging shows age- and genotype-dependent impairments in the availability of cannabinoid receptor 1 in a mouse model of Alzheimer's disease (2018)
- Neurobiology of Aging
UTU Research Portal